Menu

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Reading 0:00
15s threshold

Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year

Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.